Direkt zum Inhalt
Merck

Fortfahren mit

SML4149

Gliocidin

≥98% (HPLC), powder, IMPDH2 Inhibitor

Synonym(e):

N-3-Pyridinyl-2-thiophenecarboxamide, SW106065

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Größe/SKUVerfügbarkeitPreis

Über diesen Artikel

Empirische Formel (Hill-System):
C10H8N2OS
CAS-Nummer:
Molekulargewicht:
204.25
MDL number:
NACRES:
NA.21
UNSPSC Code:
12352200
eCl@ss:
32160701
Assay:
≥98% (HPLC)
Form:
powder
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

SMILES string

O=C(C1=CC=CS1)NC2=CC=CN=C2

Application

Gliocidin may be used to investigate its effects on glioblastoma by inhibiting cell proliferation and regulating metabolic pathways. It may also be used to induce tumor cell death in glioblastoma by targeting the de novo purine synthesis pathway through the indirect inhibition of inosine monophosphate dehydrogenase 2 (IMPDH2).

Biochem/physiol Actions

Gliocidin is a potent and low-toxic BBB-permeable prodrug that targets glioblastoma by depleting guanylates via IMPDH2 inhibition; enhances effects with temozolomide. Gliocidin, a nanomolar-potent prodrug (IC50 ~9.17 nM under Nam-depleted conditions), inhibits IMPDH2, disrupting guanine nucleotide synthesis, which is crucial for tumor DNA and RNA production. Activated via the NAD+ salvage pathway into gliocidin-adenine dinucleotide (9-AD), it selectively depletes guanylate in tumor cells, leading to cell death. Gliocidin demonstrates effective blood-brain barrier penetration (brain/plasma ratio ~7.75) and significantly reduces glioblastoma growth in vivo at 50 mg/kg intraperitoneally, twice daily, without observed toxicity. Sensitivity to nicotinamide levels (IC50 increases to 35.7 μM with 1 mM Nam) underscores its pathway dependence. Combined with temozolomide (50 mg/kg/day), gliocidin′s efficacy improves through NMNAT1 upregulation, enhancing 9-AD formation and maintaining a strong safety profile. Gliocidin is known to modulate mTOR complex 1 (mTORC1) signaling and impact purine metabolism.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
TA9H97BAEF36AABH97CD7AB6WH0003615M1
Gliocidin ≥98% (HPLC), powder, IMPDH2 Inhibitor

SML4149

Gliocidin

description

≥98% (HPLC), powder, IMPDH2 Inhibitor

description

-

description

-

description

clone 1E12-B6, purified immunoglobulin, buffered aqueous solution

form

powder

form

-

form

-

form

buffered aqueous solution

assay

≥98% (HPLC)

assay

-

assay

-

assay

-

Quality Level

100

Quality Level

-

Quality Level

-

Quality Level

100

storage temp.

-10 to -25°C

storage temp.

-

storage temp.

-

storage temp.

−20°C

solubility

DMSO: 2 mg/mL, clear

solubility

-

solubility

-

solubility

-

color

white to beige

color

-

color

-

color

-


Lagerklasse

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen